Published in Clin Lymphoma Myeloma on November 01, 2005
An evidence-based approach to the treatment of thyroid lymphoma. World J Surg (2007) 1.08
Chemotherapy, bevacizumab, and cetuximab in metastatic colorectal cancer. N Engl J Med (2009) 11.63
A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma. Blood (2007) 5.18
Recent trends of cancer in Europe: a combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s. Eur J Cancer (2008) 4.41
Double-hit B-cell lymphomas. Blood (2010) 3.19
An overview of prognostic factors for long-term survivors of breast cancer. Breast Cancer Res Treat (2007) 2.65
Less aggressive treatment and worse overall survival in cancer patients with diabetes: a large population based analysis. Int J Cancer (2007) 2.64
Prognostic impact of increasing age and co-morbidity in cancer patients: a population-based approach. Crit Rev Oncol Hematol (2005) 2.18
Predictors and survival of synchronous peritoneal carcinomatosis of colorectal origin: a population-based study. Int J Cancer (2010) 2.13
Changing epidemiology of malignant cutaneous melanoma in Europe 1953-1997: rising trends in incidence and mortality but recent stabilizations in western Europe and decreases in Scandinavia. Int J Cancer (2003) 2.13
Superior outcome of women with stage I/II cutaneous melanoma: pooled analysis of four European Organisation for Research and Treatment of Cancer phase III trials. J Clin Oncol (2012) 1.93
Platinum-based drugs disrupt STAT6-mediated suppression of immune responses against cancer in humans and mice. J Clin Invest (2011) 1.91
Socioeconomic status and changing inequalities in colorectal cancer? A review of the associations with risk, treatment and outcome. Eur J Cancer (2010) 1.77
Unfavourable pattern of metastases in M0 breast cancer patients during 1978-2008: a population-based analysis of the Munich Cancer Registry. Breast Cancer Res Treat (2011) 1.70
High long-term absolute risk of recurrent venous thromboembolism in patients with hereditary deficiencies of protein S, protein C or antithrombin. Thromb Haemost (2009) 1.64
Results of the Dutch National study of the palliative effect of irradiation using two different treatment schemes for non-small-cell lung cancer. J Clin Oncol (2005) 1.62
Comorbidity in older surgical cancer patients: influence on patient care and outcome. Eur J Cancer (2007) 1.61
The impact of the combination of baseline risk group and cytogenetic response on the survival of patients with chronic myeloid leukemia treated with interferon alpha. Haematologica (2005) 1.58
22q11.2 Deletion Syndrome is under-recognised in adult patients with tetralogy of Fallot and pulmonary atresia. Heart (2010) 1.58
Gene expression profiling in follicular lymphoma to assess clinical aggressiveness and to guide the choice of treatment. Blood (2004) 1.56
Fertility preservation after chemotherapy for Hodgkin lymphoma. Hematol Oncol (2010) 1.54
The impact of socioeconomic status on prostate cancer treatment and survival in the southern Netherlands. Urology (2013) 1.53
Sentinel node micrometastases in breast cancer do not affect prognosis: a population-based study. Breast Cancer Res Treat (2010) 1.52
Trends in incidence, therapy and outcome of localized nodal and extranodal marginal zone lymphomas: declining incidence and inferior outcome for gastrointestinal sites. Leuk Lymphoma (2013) 1.43
Gender differences in melanoma survival: female patients have a decreased risk of metastasis. J Invest Dermatol (2010) 1.42
Prognostic impact of germinal center-associated proteins and chromosomal breakpoints in poor-risk diffuse large B-cell lymphoma. J Clin Oncol (2006) 1.42
Erythropoietin is reduced by combination of diuretic therapy and RAAS blockade in proteinuric renal patients with preserved renal function. Nephrol Dial Transplant (2010) 1.42
Long-term quality of VKA treatment and clinical outcome after extreme overanticoagulation in 14,777 AF and VTE patients. Thromb Haemost (2014) 1.40
The origin of epithelial neoplasms after allogeneic stem cell transplantation. Haematologica (2006) 1.39
Lymph node retrieval in rectal cancer is dependent on many factors--the role of the tumor, the patient, the surgeon, the radiotherapist, and the pathologist. Am J Surg Pathol (2009) 1.29
Treatment of local breast carcinoma in Florida: the role of the distance to radiation therapy facilities. Cancer (2006) 1.28
Unique polycomb gene expression pattern in Hodgkin's lymphoma and Hodgkin's lymphoma-derived cell lines. Am J Pathol (2004) 1.28
Long-term risk of cardiovascular disease after treatment for aggressive non-Hodgkin lymphoma. Blood (2005) 1.28
Well-being, posttraumatic growth and benefit finding in long-term breast cancer survivors. Psychol Health (2009) 1.24
Uncommon breast tumors in perspective: incidence, treatment and survival in the Netherlands. Int J Cancer (2007) 1.23
New opportunities for drug outcomes research in cancer patients: the linkage of the Eindhoven Cancer Registry and the PHARMO Record Linkage System. Eur J Cancer (2009) 1.23
Bone mineral density and the risk of breast cancer: the Rotterdam Study. Bone (2003) 1.20
The effect of race/ethnicity and insurance in the administration of standard therapy for local breast cancer in Florida. Breast Cancer Res Treat (2005) 1.19
Which comorbid conditions predict complications after surgery for colorectal cancer? World J Surg (2007) 1.18
A population-based study of severity of comorbidity among patients with non-Hodgkin's lymphoma: prognostic impact independent of International Prognostic Index. Br J Haematol (2005) 1.18
Correlation of FCGR3A and EGFR germline polymorphisms with the efficacy of cetuximab in KRAS wild-type metastatic colorectal cancer. Eur J Cancer (2010) 1.17
Breast carcinoma diagnosis, treatment, and prognosis before and after the introduction of mass mammographic screening. Cancer (2004) 1.17
Bowel, urinary, and sexual problems among long-term prostate cancer survivors: a population-based study. Int J Radiat Oncol Biol Phys (2008) 1.16
Risk of second cancer after treatment of aggressive non-Hodgkin's lymphoma; an EORTC cohort study. Haematologica (2006) 1.15
The hospital standardized mortality ratio fallacy: a narrative review. Med Care (2012) 1.14
Mass screening programmes and trends in cervical cancer in Finland and the Netherlands. Int J Cancer (2008) 1.13
Half of breast cancer patients discontinue tamoxifen and any endocrine treatment before the end of the recommended treatment period of 5 years: a population-based analysis. Breast Cancer Res Treat (2010) 1.13
The impact of adjuvant therapy on contralateral breast cancer risk and the prognostic significance of contralateral breast cancer: a population based study in the Netherlands. Breast Cancer Res Treat (2007) 1.10
High-dose Ara-C and beam with autograft rescue in R-CHOP responsive mantle cell lymphoma patients. Br J Haematol (2008) 1.10
Confirmation of the mantle-cell lymphoma International Prognostic Index in randomized trials of the European Mantle-Cell Lymphoma Network. J Clin Oncol (2014) 1.10
Immunohistochemical profiling of caspase signaling pathways predicts clinical response to chemotherapy in primary nodal diffuse large B-cell lymphomas. Blood (2004) 1.08
Identification of RUNX1/AML1 as a classical tumor suppressor gene. Oncogene (2003) 1.08
High-dose chemotherapy with autologous stem cell support in first-line treatment of aggressive non-Hodgkin lymphoma - results of a comprehensive meta-analysis. Cancer Treat Rev (2007) 1.07
Update on the molecular pathogenesis and clinical treatment of mantle cell lymphoma: report of the 11th annual conference of the European Mantle Cell Lymphoma Network. Leuk Lymphoma (2012) 1.07
Quantitative microsatellite analysis to delineate the commonly deleted region 1p22.3 in mantle cell lymphomas. Genes Chromosomes Cancer (2006) 1.04
Novel chromosomal imbalances in mantle cell lymphoma detected by genome-wide array-based comparative genomic hybridization. Blood (2004) 1.04
Scalp cooling for hair preservation and associated characteristics in 1411 chemotherapy patients - results of the Dutch Scalp Cooling Registry. Acta Oncol (2012) 1.03
Mutation analysis of KRAS prior to targeted therapy in colorectal cancer: development and evaluation of quality by a European external quality assessment scheme. Virchows Arch (2011) 1.03
Pitfalls in TCR gene clonality testing: teaching cases. J Hematop (2008) 1.03
Decreased risk of prostate cancer after skin cancer diagnosis: a protective role of ultraviolet radiation? Am J Epidemiol (2007) 1.02
High-intensity strength training improves quality of life in cancer survivors. Acta Oncol (2007) 0.99
A high level of fatigue among long-term survivors of non-Hodgkin's lymphoma: results from the longitudinal population-based PROFILES registry in the south of the Netherlands. Haematologica (2012) 0.99
Trends in the prognosis of patients with primary metastatic breast cancer diagnosed between 1975 and 2002. Breast (2007) 0.99
Substantial increase in the use of adjuvant systemic treatment for early stage breast cancer reflects changes in guidelines in the period 1990-2006 in the southeastern Netherlands. Eur J Cancer (2008) 0.99
Explanations for worsening cancer survival. Nat Rev Clin Oncol (2010) 0.99
The influence of age and comorbidity on receiving radiotherapy as part of primary treatment for cancer in South Netherlands, 1995 to 2002. Cancer (2006) 0.98
Preparing pathology for personalized medicine: possibilities for improvement of the pre-analytical phase. Histopathology (2011) 0.97
Premature ovarian failure and fertility in long-term survivors of Hodgkin's lymphoma: a European Organisation for Research and Treatment of Cancer Lymphoma Group and Groupe d'Etude des Lymphomes de l'Adulte Cohort Study. J Clin Oncol (2011) 0.97
Prognostic significance of metallothionein in human gastrointestinal cancer. Clin Cancer Res (2002) 0.96
Early onset post-transplant lymphoproliferative disease is associated with allograft localization. Clin Transplant (2005) 0.94
The course of anxiety and depression for patients with Hodgkin's lymphoma or diffuse large B cell lymphoma: a longitudinal study of the PROFILES registry. J Cancer Surviv (2014) 0.94
Cost-utility analysis of short- versus long-course palliative radiotherapy in patients with non-small-cell lung cancer. J Natl Cancer Inst (2006) 0.94
Incidence and survival trends of uncommon corpus uteri malignancies in the Netherlands, 1989-2008. Int J Gynecol Cancer (2012) 0.93
Dose-finding study of imatinib in combination with intravenous cytarabine: feasibility in newly diagnosed patients with chronic myeloid leukemia. Blood (2008) 0.92
Promoter methylation of PARG1, a novel candidate tumor suppressor gene in mantle-cell lymphomas. Haematologica (2007) 0.92
Increased health care utilization among long-term cancer survivors compared to the average Dutch population: a population-based study. Int J Cancer (2007) 0.91
HLA antigens and post renal transplant lymphoproliferative disease: HLA-B matching is critical. Transplantation (2005) 0.90
Simple radiographic parameter predicts fracturing in metastatic femoral bone lesions: results from a randomised trial. Radiother Oncol (2003) 0.90
Geographical relationships between sociodemographic factors and incidence of cervical cancer in the Netherlands 1989-2003. Eur J Cancer Prev (2008) 0.90
Impact of external beam adjuvant radiotherapy on health-related quality of life for long-term survivors of endometrial adenocarcinoma: a population-based study. Int J Radiat Oncol Biol Phys (2007) 0.90
Fas receptor clustering and involvement of the death receptor pathway in rituximab-mediated apoptosis with concomitant sensitization of lymphoma B cells to fas-induced apoptosis. J Immunol (2007) 0.90
In normal controls, both age and gender affect coagulability as measured by thrombelastography. Anesth Analg (2010) 0.90
Trends in cervical cancer in the Netherlands until 2007: has the bottom been reached? Int J Cancer (2011) 0.89
Reactive oxygen species and melanoma: an explanation for gender differences in survival? Pigment Cell Melanoma Res (2010) 0.89
Age and co-morbidity in cancer patients: a population-based approach. Cancer Treat Res (2005) 0.89
Protein profiling of B-cell lymphomas using tissue biopsies: A potential tool for small samples in pathology. Cell Oncol (2008) 0.89
Radiotherapy is effective in patients with glioblastoma multiforme with a limited prognosis and in patients above 70 years of age: a retrospective single institution analysis. Radiother Oncol (2005) 0.88
Integrated genomic and expression profiling in mantle cell lymphoma: identification of gene-dosage regulated candidate genes. Br J Haematol (2008) 0.88
Excess of autoimmune and chronic inflammatory disorders in patients with lymphoma compared with all cancer patients: a cancer registry-based analysis in the south of the Netherlands. Autoimmun Rev (2010) 0.88
Results of radiotherapy in 153 primary cutaneous B-Cell lymphomas classified according to the WHO-EORTC classification. Arch Dermatol (2007) 0.88
Fatigue mediates the relationship between physical fitness and quality of life in cancer survivors. J Sci Med Sport (2012) 0.87
Outcome of radiotherapy in T1 glottic carcinoma: a population-based study. Eur Arch Otorhinolaryngol (2008) 0.86